Highlights Malin Corporation plc

Equities

MLC

IE00BVGC3741

Market Closed - Irish S.E. Other stock markets 16:55:00 09/05/2024 BST			5-day change	1st Jan Change
5.6 ^EUR	+0.90%		0.00%	+24.44%

05-01	Malin Corp investee signs agreement with Astellas Pharma	AN
03-28	Transcript : Malin Corporation plc - Shareholder/Analyst Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Malin Corp investee signs agreement with Astellas Pharma	05-01	AN
EARNINGS: Hutchmed revenue surges, Craven House's loss widens	02-28	AN
Tranche Update on Malin Corporation plc's Equity Buyback Plan announced on November 15, 2023.	02-28	CI
Puma and Puma Alpha invest in Not Another Beer	01-26	AN
Malin Corporation plc commences an Equity Buyback Plan, under the authorization approved on March 10, 2023.	11-15	CI
Malin Corporation plc Reports Earnings Results for the Half Year Ended June 30, 2023	06/09/23	CI
Solid State sees strong orders in security & defence	06/09/23	AN
Tranche Update on Malin Corporation plc's Equity Buyback Plan announced on February 16, 2023.	21/03/23	CI
Malin Corporation plc's Equity Buyback announced on February 16, 2023, has closed with repurchase of 15,053,763 shares, representing 44.25% for €140 million.	19/03/23	CI
Malin confident heading into 2023; proposes investor return	16/02/23	AN
Malin to return up to EUR140 million to shareholders	16/02/23	AN
Malin Starts Tender Offer for Shares	16/02/23	MT
Malin Corporation plc announces an Equity Buyback for 15,053,763 shares, representing 44.25% for €140 million.	16/02/23	CI
Malin Corporation plc Reports Earnings Results for the Full Year Ended December 31, 2022	15/02/23	CI
An unknown buyer agreed to acquire a 44.280983% stake in Malin Corporation plc for €140 million.	15/02/23	CI
Malin Corporation plc authorizes a Buyback Plan.	15/02/23	CI
TRADING UPDATES: CyanConnode to raise funds; Pure Gold cancels listing	23/01/23	AN
Malin Pockets EUR145 Million in Exit from Biotechnology Company Immunocare	07/12/22	MT
An unknown buyer acquired a 5% stake in Immunocore Holdings plc from Malin Corporation plc for approximately €150 million.	06/12/22	CI
Malin Settles Legal Dispute With Founders Over Share Conversion Claims	13/10/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Malin Corporation plc

Equities

MLC

IE00BVGC3741

Highlights

Filters